spacer
spacer

PDBsum entry 1ftv

Go to PDB code: 
Top Page protein ligands links
Hydrolase/hydrolase inhibitor PDB id
1ftv
Contents
Protein chain
218 a.a.
Ligands
E6C

References listed in PDB file
Key reference
Title Kinetic and crystallographic studies of glucopyranose spirohydantoin and glucopyranosylamine analogs inhibitors of glycogen phosphorylase.
Authors K.A.Watson, E.D.Chrysina, K.E.Tsitsanou, S.E.Zographos, G.Archontis, G.W.Fleet, N.G.Oikonomakos.
Ref. Proteins, 2005, 61, 966-983. [DOI no: 10.1002/prot.20653]
PubMed id 16222658
Abstract
Glycogen phosphorylase (GP) is currently exploited as a target for inhibition of hepatic glycogenolysis under high glucose conditions. Spirohydantoin of glucopyranose and N-acetyl-beta-D-glucopyranosylamine have been identified as the most potent inhibitors of GP that bind at the catalytic site. Four spirohydantoin and three beta-D-glucopyranosylamine analogs have been designed, synthesized and tested for inhibition of GP in kinetic experiments. Depending on the functional group introduced, the K(i) values varied from 16.5 microM to 1200 microM. In order to rationalize the kinetic results, we determined the crystal structures of the analogs in complex with GP. All the inhibitors bound at the catalytic site of the enzyme, by making direct and water-mediated hydrogen bonds with the protein and by inducing minor movements of the side chains of Asp283 and Asn284, of the 280s loop that blocks access of the substrate glycogen to the catalytic site, and changes in the water structure in the vicinity of the site. The differences observed in the Ki values of the analogs can be interpreted in terms of variations in hydrogen bonding and van der Waals interactions, desolvation effects, ligand conformational entropy, and displacement of water molecules on ligand binding to the catalytic site.
Figure 1.
Figure 1. A schematic diagram of the GPb dimeric molecule viewed down the molecular dyad. One subunit is colored in dark green and the other in light green. The position is shown for the catalytic site. The catalytic site, marked by glucose (GLC) and the essential cofactor pyridoxal 5 -phosphate (PLP), shown in ball-and-stick representations, is buried at the center of the subunit and is accessible to the bulk solvent through a 15-Å long channel. Close-up: Details of the interactions of glucose with residues of the catalytic site. -D-Glucose, a competitive inhibitor (K[i] = 1.7 mM), on binding at the catalytic site, promotes the less active T state through stabilization of the closed position of the 280s loop (shown in cream) which blocks access for the substrate (glycogen) to the catalytic site. In particular, the -1-OH is hydrogen-bonded to Asp283 (OD1), through a water molecule, and the 2-OH is hydrogen-bonded directly to Asn284 (ND2).
Figure 2.
Figure 2. Interactions of compound 1 (A), compound 2 (B), compound 3 (C), compound 4 (D), compound 5 (E), compound 6 (F), compound 7 (G), compound 8 (H), compound 8, 100 K (I), compound 9 (J), compound 10 (K) with GPb in the vicinity of the catalytic site, shown in stereo. The interactions of the glucopyranose ring are retained throughout the structures analyzed and were not incorporated in the figures for clarity reasons.
The above figures are reprinted by permission from John Wiley & Sons, Inc.: Proteins (2005, 61, 966-983) copyright 2005.
Secondary reference #1
Title Crystal structure of an actinidin-E-64 complex.
Authors K.I.Varughese, Y.Su, D.Cromwell, S.Hasnain, N.H.Xuong.
Ref. Biochemistry, 1992, 31, 5172-5176. [DOI no: 10.1021/bi00137a012]
PubMed id 1606141
Full text Abstract
Secondary reference #2
Title Refined X-Ray structure of papain.E-64-C complex at 2.1-A resolution.
Authors D.Yamamoto, K.Matsumoto, H.Ohishi, T.Ishida, M.Inoue, K.Kitamura, H.Mizuno.
Ref. J Biol Chem, 1991, 266, 14771-14777.
PubMed id 1860874
Abstract
Secondary reference #3
Title Structure of actinidin, After refinement at 1.7 angstroms resolution
Author E.N.Baker.
Ref. j mol biol, 1980, 141, 441.
Secondary reference #4
Title Crystal structure of a caricain d158e mutant in complex with e-64.
Authors N.A.Katerelos, M.A.Taylor, M.Scott, P.W.Goodenough, R.W.Pickersgill.
Ref. FEBS Lett, 1996, 392, 35-39. [DOI no: 10.1016/0014-5793(96)00697-7]
PubMed id 8769310
Full text Abstract
Secondary reference #5
Title Mode of binding of e-64-C, A potent thiol protease inhibitor, To papain as determined by X-Ray crystal analysis of the complex.
Authors K.Matsumoto, D.Yamamoto, H.Ohishi, K.Tomoo, T.Ishida, M.Inoue, T.Sadatome, K.Kitamura, H.Mizuno.
Ref. FEBS Lett, 1989, 245, 177-180. [DOI no: 10.1016/0014-5793(89)80216-9]
PubMed id 2924921
Full text Abstract
Secondary reference #6
Title The importance of val-157 hydrophobic interaction for papain inhibitory activity of an epoxysuccinyl amino acid derivative. A structure-Activity relationship based on the crystal structure of the papain-E-64-C complex.
Authors D.Yamamoto, K.Matsumoto, H.Ohishi, T.Ishida, M.Inoue, K.Kitamura, K.Hanada.
Ref. FEBS Lett, 1990, 263, 134-136. [DOI no: 10.1016/0014-5793(90)80722-U]
PubMed id 2332044
Full text Abstract
Secondary reference #7
Title Crystal structure of papain-E64-C complex. Binding diversity of e64-C to papain s2 and s3 subsites.
Authors M.J.Kim, D.Yamamoto, K.Matsumoto, M.Inoue, T.Ishida, H.Mizuno, S.Sumiya, K.Kitamura.
Ref. Biochem J, 1992, 287, 797-803.
PubMed id 1445241
Abstract
PROCHECK
Go to PROCHECK summary
 Headers

 

spacer

spacer